Phase II/III of Recombinant Human Serum Albumin

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a randomized, double-blind, position-controlled, parallel group phase II/III clinical study of recombinant human serum albumin (rHSA) in cirrhotic ascites patients.
Epistemonikos ID: 88fc35e7b0b9a4ebf037b00bac18b92d3bf5ce9d
First added on: Feb 19, 2024